Skip to content
Baret News – Lifestyle
Author:
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
April 7, 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
March 18, 2026
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
March 9, 2026
←
Previous Page
1
2